Infection Control AseptiScope focuses on addressing healthcare associated infections with the DiskCover System, presenting a clear value proposition for hospital infection control teams and procurement managers seeking barrier solutions for stethoscope contamination.

US Market Launch Full-scale US launch achieved in 2022, signaling maturity in commercialization and readiness to scale with healthcare systems, distributors, and GPOs across acute care, long-term care, and outpatient settings.

Clinical Validation Founded by clinical market experts and clinicians and recognized as Infection Control Company of the Year in 2020, enabling credibility with risk and compliance officers, infection preventionists, and purchasing committees.

Growing Revenue Current revenue range ($1M–$10M) with notable funding ($8.1M) indicates growth potential; target opportunities include expanding into mid- to large-size healthcare facilities and leveraging private equity or venture-backed adopters seeking innovative infection control devices.

Digital & Security Stack Tech stack elements (Cloudflare, HTTP/3, reCAPTCHA, Nginx, Elementor, Gravity Forms) suggest strong web presence and secure lead capture; leverage for digital marketing, educational content, and region-specific campaigns to drive inquiries from infection prevention teams.